ARS Pharmaceuticals, Inc.

NasdaqGM:SPRY Stock Report

Market Cap: US$798.4m

ARS Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:SPRY Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Mar 24BuyUS$13,289,410RA Capital Management, L.P.Company1,401,299US$9.79
29 Sep 23BuyUS$319,954Alexander FitzpatrickIndividual86,258US$3.78
21 Sep 23BuyUS$8,183,526RA Capital Management, L.P.Company2,700,000US$3.83
29 Aug 23SellUS$26,350,000Robert BellIndividual4,250,000US$6.20
29 Aug 23BuyUS$3,100,000OrbiMed Advisors LLCCompany500,000US$6.20
29 Aug 23BuyUS$23,250,000RA Capital Management, L.P.Company3,750,000US$6.20

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SPRY?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,296,1773.4%
Hedge Funds11,077,92711.4%
General Public13,381,90913.8%
Individual Insiders19,490,63120.1%
VC/PE Firms20,101,86420.7%
Institutions29,546,74830.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.


Top Shareholders

Top 25 shareholders own 79.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
Deerfield Management Company, L.P. Series C
11,077,927US$91.3m0%1.74%
11.2%
RA Capital Management, L.P.
10,860,977US$89.5m14.8%1.23%
9.54%
OrbiMed Advisors LLC
9,240,887US$76.1m0%1.1%
6.05%
Richard Lowenthal
5,861,807US$48.3m-24.6%no data
4.98%
Pratik Shah
4,824,554US$39.8m-52.5%no data
4.35%
Robert Bell
4,213,504US$34.7m0%no data
4.14%
SR One Capital Management, LP
4,012,903US$33.1m0%9.71%
3.52%
Sarina Tanimoto
3,407,847US$28.1m4%no data
3.4%
The Lowenthal-Tanimoto Family Trust
3,295,946US$27.2m94.2%no data
3.05%
Franklin Resources, Inc.
2,950,709US$24.3m-28%0.01%
2.98%
The Vanguard Group, Inc.
2,886,455US$23.8m37%no data
2.74%
BlackRock, Inc.
2,658,239US$21.9m0.78%no data
2.29%
K2 & Associates Investment Management Inc.
2,219,131US$18.3m-27.3%9.84%
1.97%
Nextech Invest Ltd.
1,910,029US$15.7m0%2.62%
1.66%
State Street Global Advisors, Inc.
1,604,550US$13.2m178%no data
1.12%
FMR LLC
1,084,922US$8.9m-9.76%no data
0.9%
Geode Capital Management, LLC
876,671US$7.2m1.36%no data
0.9%
Perceptive Advisors LLC
867,319US$7.1m0%0.15%
0.66%
Rubric Capital Management LP
639,203US$5.3m0%0.11%
0.66%
Medical Strategy GmbH, Asset Management Arm
638,980US$5.3m0%0.31%
0.58%
Royce & Associates, LP
558,700US$4.6m17.9%0.04%
0.55%
Sio Capital Management, LLC
536,163US$4.4m-51.5%1.66%
0.41%
Woodline Partners LP
401,788US$3.3m-39.3%0.03%
0.41%
Invesco Capital Management LLC
399,528US$3.3m16,800%no data
0.39%
Valerie Odegard
382,236US$3.1m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.